Switching from Analog to Human Insulin

Both the House and Senate opened hearings on the cost of prescription drugs on Tuesday, with the House Oversight and Reform committee and the Senate Finance committee taking testimony from families of patients, advocates, and leading researchers, including Peter Bach, MD, MAPP, director, Memorial Sloan Kettering Center for Health Policy and Outcomes; Avik Roy, president of the Foundation for Research on Equal Opportunity; and Aaron S. Kesselheim, MD, JD, MPH, of Harvard Medical School.

View Article